Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited is an Indian listed company in the Agricultural Food & other Products industry (Fast Moving Consumer Goods sector), traded under NSE: NATHBIOGEN and BSE: 537291 (ISIN INE448G01010).
It has a market capitalisation of ₹258 crore, a last close of ₹135.71 on 2026-10-19, a one-year return of -18.8%.
Valuation: a price-to-book ratio of 0.38x, a dividend yield of 1.5%.
Profitability: return on equity of 0.0%, return on capital employed of 9.1%, an operating margin of 10.1%.
Growth: sales growth of 13.9% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.20x, promoter holding of 45.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 258 |
| Last close | ₹135.71 |
| P/B | 0.38x |
| Dividend yield | 1.5% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 9.1% |
| Operating margin (TTM) | 10.1% |
| Sales growth, 3-year CAGR | 13.9% |
| Debt / equity | 0.20x |
| Promoter holding | 45.6% |
| 1-year return | -18.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means